n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine has been researched along with loratadine in 1 studies
Studies (n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine) | Trials (n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine) | Recent Studies (post-2010) (n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine) | Studies (loratadine) | Trials (loratadine) | Recent Studies (post-2010) (loratadine) |
---|---|---|---|---|---|
113 | 0 | 9 | 1,317 | 462 | 339 |
Protein | Taxonomy | n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine (IC50) | loratadine (IC50) |
---|---|---|---|
Cytochrome P450 2C19 | Homo sapiens (human) | 0.016 | |
Histamine H1 receptor | Homo sapiens (human) | 0.23 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.245 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.1717 | |
Bile acid receptor | Homo sapiens (human) | 3.07 | |
Sodium-dependent neutral amino acid transporter B(0)AT2 | Homo sapiens (human) | 4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ejiri, Y; Kotake, Y; Ohta, S; Sanoh, S; Santoh, M; Takagi, M | 1 |
1 other study(ies) available for n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine and loratadine
Article | Year |
---|---|
Detection of metabolic activation leading to drug-induced phospholipidosis in rat hepatocyte spheroids.
Topics: Animals; Cell Culture Techniques; Cells, Cultured; Cytochrome P-450 Enzyme System; Fluorescent Dyes; Hepatocytes; Loratadine; Phosphatidylethanolamines; Phospholipids; Rats, Sprague-Dawley; Spheroids, Cellular; Surface-Active Agents | 2016 |